Our study specifically determined that IGF-1/IGF-1R signaling via the PI3-K and MAPK pathways augments the invasive phenotype of these prostate cancer cells, and that this regulation is at least partially attributed to an increase in the activity, but not necessarily in the expression, of MMP-2 and MMP-9. The gene discussed is MMP9; the disease is Familial prostate cancer.